Cardihab
Melissa Mail is an Investment Manager at Uniseed – an early-stage commercialisation fund supported by four outstanding Australian universities and CSIRO. Melissa has significant experience across a broad range of sectors including scientific research, food and agriculture, health, and software. Melissa brings a broad strategic perspective with a focus on technology performance and aligning intellectual property assets with commercial strategy.
Melissa holds a Bachelor of Science (Honours) from Monash University, a PhD from the University of Melbourne, a Bachelor of Laws (Honours) from Macquarie University and a Master of Intellectual Property Law from the University of Technology Sydney. Melissa is a Fellow of the Institute of Patent and Trade Mark Attorneys and a graduate of the Australian Institute of Company Directors.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Cardihab
Cardihab provides clinicians with the ability to remotely deliver a comprehensive Phase 2 CR program based on ACRA guidelines.